TRANSGENIC ANIMAL MODEL OF MOOD DISORDERS

Detection method for NTRK3 fusion

High temperature selection of nucleotide-supported carbohydrate vaccines and resulting glycosylated oligonucleotides

Methods for diagnosing osteoarthritis

Kits and methods for evaluating, selecting and characterizing tissue culture models using micro-RNA profiles

Targeted augmentation of nuclear gene output

SnoRNA, compositions and uses

METHOD FOR DETERMINING THE CARDIO-GENERATIVE POTENTIAL OF MAMMALIAN CELLS

MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS

Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1

Methods for identifying therapeutic targets and treating monitoring cancers

USE OF MICRORNA 146-A IN THE DIAGNOSIS, TREATMENT AND PREVENTION OF PICORNAVIRUS INFECTION AND MICRORNA 146-A ANTAGONISTS

METHODS FOR DETERMINING THE EFFECTS OF COMPOUNDS ON JAK/STAT ACTIVITY

Breast cancer biomarkers and methods of using same

METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE (AD) USING THE MOLECULES THAT STABILIZE INTRACELLULAR CALCIUM (Ca2+) RELEASE

TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

SCREENING ASSAY FOR AGENTS THAT INFLUENCE BETA CELL NUMBER AND/OR PHENOTYPE

Methods of using miRNAs from bodily fluids for detection and monitoring of Parkinson's disease (PD)

Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3

Antibody specific to the AIMP2-DX2

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

Phage microarray profiling of the humoral response to disease

Methods of determining interferon having direct inhibitory effects on tumors and uses thereof

DDX43 as a biomarker of resistance to MEK1/2 inhibitors

Host DNA as a biomarker of Crohn's disease

Use of sting agonists to treat hepatitis B virus infection

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

Methods for inhibiting muscle atrophy

RNA disruption assay for predicting survival

RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders

Methods for Selecting Medications

Markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasia

METHODS OF TREATING ALZHEIMER'S DISEASE

Dynamic flux nucleic acid sequence amplification

TREATMENT OF METABOLIC DISEASES BY INHIBTION OF HTR2A OR HTR3

Compositions and methods for the identification of inhibitors of retroviral infection

Pestivirus species

METHODS FOR DIAGNOSING ISCHEMIA

Anti-tumor therapy

MEK1 mutation conferring resistance to RAF and MEK inhibitors

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

Cancer biomarker and diagnostic

BACTERIAL SIGNATURE OF ATOPIC DERMATITIS AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF THIS PATHOLOGY

Modulators of alpha-synuclein toxicity

Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression

Methods for use of small molecule activators of hem-Y / protoporphyrinogen oxidase (PPO)

USE OF DECTIN-1 ACTIVATORS FOR TREATMENT OF LIVER DISORDERS

ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS

Assay for drug discovery based on in vitro differentiated cells

MIPOL1-ETV1 gene rearrangements

Quantification of Lamin C and Lamin A for tumor classification

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

Use of RHOA in cancer diagnosis and inhibitor screening

Targeting of podoplanin with lectin for use in the prevention and treatment of cancer

USE OF ARPIN A NEW INHIBITOR OF THE ARP2/3 COMPLEX FOR THE DIAGNOSIS AND TREATMENT OF DISEASES

A BIOMARKER OF BREAST CANCER

Methods of Detecting Diseases or Conditions Using Phagocytic Cells

Ligase E3 RNF185 inhibitors and uses thereof

COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY

Detection and treatment of LRP4-associated neurotransmission disorders

SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT

PREVOTELLA COPRI AND ENHANCED SUSCEPTIBILITY TO ARTHRITIS

Preventive and therapeutic drug for cartilaginous hyperplasia and method of screening for the same

COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEM

FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases

Tomatidine, analogs thereof, compositions comprising same, and uses for same

COMPOSITION CONTAINING PYRUVATE DEHYDROGENASE KINASE INHIBITOR FOR TREATING CHRONIC INFLAMMATORY PAIN

ASSAY METHODS FOR THE DETERMINATION OF FKBPL EXPRESSION LEVEL IN THE CONTEXT OF BREAST CANCER

TREATMENT OF INSULIN GENE (INS) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN INSULIN GENE (INS)

Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)

Methods and compositions for treating and diagnosing diseases

Tyrosine kinome

Methods of Detecting Neurological or Neuropsychiatric Diseases or Conditions

Methods of Detecting Kidney-Associated Diseases or Conditions

METHODS OF PREDICTING TOXICITY

AMDINOCILLIN FOR RAPID DETERMINATION OF SUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS

Methods of detecting autoimmune or immune-related diseases or conditions

Methods of Detecting Cardiovascular Diseases or Conditions

Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, the causative agent of heartworm disease

Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms

Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor

Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes

Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease

METHOD FOR SCREEING CANCER METASTASIS INHIBITOR USING CULTURE OF CELLS OR SPHEROIDICALLY AGGREGATED CELLS IN WHICH LYSYL-TRNA SYNTHETASE IS REGULATED TO BE EXPRESSED OR UNEXPRESSED

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

Methods of detecting prenatal or pregnancy-related diseases or conditions

BIOMARKER FOR SENESCENCE AND USE THEREOF

AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION

Screening methods for cognitive enhancers

Methods for monitoring methotrexate therapy

Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF

NGAL AND URINARY TRACT INFECTION

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

EFFICIENT FUNCTIONAL GENOMICS PLATFORM

Screening Method for Identifying Active Agents

METHOD OF SCREENING FOR CHAPERONIN MODULATOR

METHODS OF TREATING ATHEROSCLEROSIS

Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cells

USE OF A SLC MAMMALIAN SKIN TRANSPORTER

Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

PERINUCLEOLAR COMPARTMENT AS A CANCER MARKER

THERAPIES FOR CARDIOMYOPATHY

PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM

ASSAYS, METHODS AND KITS FOR ANALYZING SENSITIVITY AND RESISTANCE TO ANTI-CANCER DRUGS, PREDICTING A CANCER PATIENT'S PROGNOSIS, AND PERSONALIZED TREATMENT STRATEGIES

Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders

Primer reagent for amplifying ALK fusion gene, ALK fusion gene amplification reagent kit including the same, and ALK fusion gene amplification method and ALK fusion gene analysis method using the same

Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism

Method of Improving Aging Appearance of Skin by Modulation of WIPI-1

Prophylactic and/or therapeutic agent for inflammatory disease, and method for screening prophylactic and/or therapeutic drug for inflammatory disease

Compositions and methods for inhibiting HMGB1 activation of melanocytes

Method of making a skin care composition

Allogeneic autophagosome-enriched composition for the treatment of disease

Molecular targets for ALS and related disorders

METHOD FOR SCREENING SKIN BARRIER FUNCTION ENHANCING AGENT BASED ON EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL, AND SKIN BARRIER FUNCTION EVALUATION METHOD

Markers for diagnosis of pulmonary inflammation and methods related thereto

Polynucleotides and polypeptide sequences involved in the process of bone remodeling

Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays

Islet1 (ISl1) and hearing loss

MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION

Markers of acute myeloid leukemia stem cells

Genetic amplification of IQGAP1 in cancer

Viral and viral associated miRNAs and uses thereof

Common and rare genetic variations associated with common variable immunodeficiency (CVID) and methods of use thereof for the treatment and diagnosis of the same

Targeting chromatin modifiers for the treatment of medical conditions

HSA-MIR-146B-5P-related nucleic acids and uses thereof

Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of nonalcoholic steatohepatitis

Biomarker for detecting white matter stroke, containing toll-like receptor 2, and medical use of toll-like receptor 2

Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient

Biological Materials and Uses Thereof

Compounds and matrices for use in bone growth and repair

METHODS FOR TREATING CANCER

Use of SHROOM3 in chronic kidney disease and chronic allograft nephropathy

Methods of using ZSCAN4 for rejuvenating human cells

METHODS OF DIAGNOSING AND TREATING FIBROSIS

METHODS FOR IDENTIFYING NEUROPROTECTIVE PKC ACTIVATORS

Assay and method for identifying compounds that reduce SIL1 expression or activity

SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers

Identification of cancer protein biomarkers using proteomic techniques

Process for evaluating active agent(s) capable of preserving the functionality of epithelial stem cells

Animal model of Charcot-Marie-Tooth disease as HSP27 mutant (S135F) carrier

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Genes expressed in mental illness and mood disorders

Nutrient combinations for affecting an aging process

METHODS AND KITS FOR DETECTING MELANOMA

Method for examination of carcinogenic risk

METHOD FOR ESTABLISHING THE SOURCE OF INFECTION IN A CASE OF FEVER OF UNCLEAR AETIOLOGY

Compositions and methods for enhancing odorant receptor activity

Methods and compositions of predicting activity of retinoid X receptor modulator

USE OF VEGFR1 AS A BIOMARKER

Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)

miRNA-124 as a biomarker

T cell balance gene expression, compositions of matters and methods of use thereof

PAK1 INHIBITION FOR TREATMENT OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

MARKERS FOR LIPID METABOLISM

Markers for breast cancer

MARKERS FOR ACUTE LYMPHOBLASTIC LEUKEMIA

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

Method of screening compounds for the treatment of diabetes

DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA

ANIMAL MODEL WITH A FILAGGRIN GENE PROMOTER

Core Transcriptional Circuitry in Human Cells and Methods of Use Thereof

Microbiome Modulation Index

PGC-1beta-protein-function regulator, mitochondria-function regulator, anti-obesity agent, and screening method therefor

USE OF MiR-26 FAMILY AS A PREDICTIVE MARKER FOR HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY

Methods of Detecting Diseases or Conditions Using Phagocytic Cells

COMPOSITION FOR TREATING EPSTEIN-BARR VIRUS INFECTION, COMPRISING EPSTEIN-BARR VIRUS MICRO RNA INHIBITOR

LONG NON-CODING RNA USED FOR ANTICANCER THERAPY

METHODS FOR TREATMENT OF MELANOMA

Method for screening lactic acid bacteria having immunoregulatory function

Compositions and methods for regulating thermogenesis and muscle inflammation using metrnl and metrn

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Methods of predicting clinical course and treating multiple sclerosis

Identification of novel genes coding for small temporal RNAs

Kit comprising primers for amplifying ALK kinase domain nucleic acids

METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS

ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME

Multiple targeted RNAI for the treatment of cancers

ANTI-INFLAMMATORY AGENTS

MEANS AND METHOD FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator

Methods of Using Biomarkers for the Treatment of Cancer by Modulation of BCL2 Expression

Genetic alterations on chromosomes 21Q, 6Q and 15Q and methods of use thereof for the diagnosis and treatment of type 1 diabetes

Competitive modulation of microRNAs

USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER

Methods for novel drug discovery, treatment and selective targeting for gefitinib-resistant non-small-cell lung cancer harboring T790M mutation

ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS

Treatment of angiogenesis disorders

SELECTIVE REDUCTION OF ALLELIC VARIANTS

RNA polymerase I inhibitors and uses thereof

Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method

TARGET INHIBITION MAP SYSTEM FOR COMBINATION THERAPY DESIGN AND METHODS OF USING SAME

SEBOCYTE CELL CULTURING AND METHODS OF USE

Method for identifying compound for inhibiting an activity of a histone lysine demethylase

Production of midbrain dopaminergic neurons and methods for the use thereof

Androgen receptor variants and methods for making and using

Cancer marker and utilization thereof

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

Methods for predicting age and identifying agents that induce or inhibit premature aging

Agents for reversing epigenetic silencing of genes

Methods for the identification, assessment, and treatment of patients with cancer therapy

Method for diagnosing a neurodegenerative disease

Piggy back delivery of nucleic acids into organisms

3D Tissue Culture Devices and Systems

ANTIVIRAL TREATMENT OF LYMPHOMA AND CANCER

CANCER MARKER AND THE USE THEREOF

IRHOM2 INHIBITION FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Functional genomics screening platform for head and neck cancer

Use of regulatory T cell-specific surface protein LRIG-1

Use of miR-494 to modulate TRAIL-induced apoptosis through BIM down-regulation

Method for quantifying different viral forms of the DNA of the HIV virus

METHODS AND COMPOSITIONS RELATING TO DIAGNOSING AND TREATING RECEPTOR TYROSINE KINASE RELATED CANCERS

USE OF POST-TRANSCRIPTIONAL GENE SILENCING FOR IDENTIFYING NUCLEIC ACID SEQUENCES THAT MODULATE THE FUNCTION OF A CELL

Methods and compositions for treating neurological disease

METHODS FOR IDENTIFYING SUBJECTS WITH AN INCREASED LIKELIHOOD OF RESPONDING TO CCR1 ANTAGONIST

MiRNA for treating head and neck cancer

Therapy with enterotoxin to treat ovarian and uterine cancer

Use of HLA-B*1301 allele

METHODS OF USING THE CALCINEURIN A VARIANT CNAB1 FOR THE TREATMENT OF CARDIAC HYPERTROPHY

TIF1-Gamma for Treating and Diagnosing Inflammatory Diseases

Modulators of hepatic lipoprotein metabolism

Methods using Axl as a biomarker of epithelial-to-mesenchymal transition

Methods of Screening for Susceptibility to Virus Infection

METHOD FOR REPLICATING HCV IN VITRO

Human hepatoma cell line HLCZ01 and uses thereof

BIOMARKERS AND METHODS FOR DETERMINING EFFICACY OF ANTI-EGFR ANTIBODIES IN CANCER THERAPY

Biomarkers for subtypes of cervical cancer

DOWNREGULATION OF miR-218 MAY BE USED AS A BIOMARKER FOR HUMAN ALS

Agent for treating cancer

Methods for diagnosing, prognosing and treating muscular dystrophy

FILAGGRIN PRODUCTION PROMOTER, THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH REDUCTION IN PRODUCTION OF FILAGGRIN, AND METHOD FOR SCREENING FOR SAID THERAPEUTIC AGENT

Method of improving aging appearance of skin by modulation of WIPI-1

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

Diagnostic and screening methods for atopic dermatitis

MODULATION OF TRANSTHYRETIN EXPRESSION

Methods for treatment of cardiovascular disease

PLASMA MICRORNAS FOR THE DETECTION OF EARLY COLORECTAL CANCER

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

HISTONE DEACETYLASE 6 (HDAC6) BIOMARKERS IN MULTIPLE MYELOMA

Quantitative Assessment of Human T-Cell Repertoire Recovery After Allogeneic Hematopoietic Stem Cell Transplantation

Immortalized mesenchymal stromal cell from adipose tissue

MARKERS ASSOCIATED WITH HUMAN DOUBLE MINUTE 2 INHIBITORS

MIRNAS AS THERAPEUTIC TARGETS IN CANCER

USP37 inactivation as a treatment for PLZF/RARA-associated acute promyelocytic leukemia

METHODS FOR DETERMINING RESPONSIVENESS TO A DIHYDROFOLATE REDUCTASE INHIBITOR

DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia

Therapeutic targets for Alzheimer's disease

IDENTIFICATION OF INHIBITORS OF A BACTERIAL STRESS RESPONSE

Method of screening for plant defense activators, plant defense activators, and method of enhancing immune response

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

Identification of New Therapeutic Uses for Known Therapeutic Agents

Probe or probe set for evaluating influence of ultraviolet ray on skin and nucleic acid microarray

Treatment of Neurodegeneration and Neuroinflammation

Methods and compositions for treating neuroblastoma

Personalized immunotherapy against several neuronal and brain tumors

Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8

RNA products and uses thereof

Methods and compositions for improving gut microbiota population

Methods and compositions for identifying, diagnosing, and treating neuroblastoma

Methods for altering mRNA splicing and treating familial dysautonomia by administering benzyladenine

CELLULAR APOBEC3 PROTEINS AND MODULATORS THEREOF FOR REGULATING DNA REPAIR PROCESSES AND TREATING PROLIFERATIVE DISEASES

Gene amplification of coactivator CoAA and uses thereof

IDENTIFICATION OF DISEASE-DRIVING ANTIGENS

Methods for the treatment and diagnosis of bone mineral density related diseases

Materials and methods useful for affecting tumor cell growth, migration and invasion

Nutrient combinations for affecting an aging process

C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS

Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

MODULATION OF LINE-1 REVERSE TRANSCRIPTASE

Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO

PHARMACEUTICAL COMPOSITION FOR VIRAL TREATMENT, AND METHOD FOR SCREENING ANTIVIRAL AGENT

Identification and use of novopeptides for the treatment of cancer

Methods for genome-wide screening and construction of genetic interaction maps

Use of RBM39 as a biomaker

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

S100A8/A9 as a Diagnostic Marker and a Therapeutic Target

USE OF VGII3 ACTIVITY MODULATOR FOR THE MODULATION OF ADIPOGENESIS

THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS

REAL-TIME PCR DETECTION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX

EDITING PROFILING OF PDE8A PRE -MRNA: USE AS SPECIFIC BIOMARKER OF ADARS ACTIVITIES IN HUMAN TISSUES TO DIAGNOSE AND TO PREDICT AND ASSESS THERAPEUTIC EFFICACY AND/OR EFFICIENCY OR POTENTIAL DRUG SIDE EFFECTS

Method for treating synovial sarcoma

INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN

Pharmaceutical compositions for treating cancer

Transgenic animal model of mood disorders

Endometrial phase or endometrial cancer biomarkers

Method for identifying immunoreactive peptides

Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms

Transformed human pluripotent stem cells and associated methods

MiRNA based treatment monitoring in multiple sclerosis

COMPOSITIONS AND METHODS FOR HIGH-THROUGHPUT SCREENING IN SKIN FIBROBLASTS WITH AN ALPHA-SYNUCLEIN TRIPLICATION

Mutations of the GPR179 Gene in Congenital Stationary Night Blindness

Method of evaluating inhibitory effect on damp-dry malodor

Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders

METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING

MicroRNA signatures in human ovarian cancer

MOLECULAR PROFILING FOR CANCER

Detecting and quantifying cryptic HIV replication

Genetic alterations associated with type I diabetes and methods for use thereof for diagnosis and treatment

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER